Cargando…

Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry

BACKGROUND: Despite great advances with the introduction of ticagrelor and prasugrel in the treatment of acute coronary syndromes (ACS), the risk of thrombosis and bleeding remains significant and affects the choice of clinicians in the treatment of the single patient. Large registries are effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcucci, Rossella, Patti, Giuseppe, Calabrò, Paolo, Gori, Anna Maria, Grossi, Guido, Cirillo, Plinio, Pengo, Vittorio, Gresele, Paolo, Pignatelli, Pasquale, Antonucci, Emilia, di Mario, Carlo, Valente, Serafina, Palareti, Gualtiero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629086/ https://www.ncbi.nlm.nih.gov/pubmed/31306454 http://dx.doi.org/10.1371/journal.pone.0219676

Ejemplares similares

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome
por: Patti, Giuseppe, et al.
Publicado: (2017)

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation
por: Antonucci, Emilia, et al.
Publicado: (2015)

Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register
por: Poli, Daniela, et al.
Publicado: (2022)

Clinical Phenotypes of Atrial Fibrillation and Mortality Risk—A Cluster Analysis from the Nationwide Italian START Registry
por: Pastori, Daniele, et al.
Publicado: (2022)

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
por: Pastori, Daniele, et al.
Publicado: (2019)

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register
por: Poli, Daniela, et al.
Publicado: (2022)

Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register
por: Palareti, Gualtiero, et al.
Publicado: (2021)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago
por: Palareti, Gualtiero, et al.
Publicado: (2017)

Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion
por: De Gregorio, Maria Grazia, et al.
Publicado: (2020)

Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants
por: Testa, Sophie, et al.
Publicado: (2019)

Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM study
por: Poli, Daniela, et al.
Publicado: (2018)

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study
por: Palareti, Gualtiero, et al.
Publicado: (2019)

Management and 1-Year Outcome in Elderly Patients with Hip Fracture Surgery Receiving Anticoagulation (Warfarin or DOAc) or P2Y12 Antiplatelet Agents
por: Rostagno, Carlo, et al.
Publicado: (2023)

Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study
por: Menichelli, Danilo, et al.
Publicado: (2021)

Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study
por: Poli, Daniela, et al.
Publicado: (2019)

Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study
por: Fabbri, Andrea, et al.
Publicado: (2013)

Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
por: Gragnano, Felice, et al.
Publicado: (2022)

Platelet Reactivity in Hepatitis C Virus–Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome
por: Scudiero, Fernando, et al.
Publicado: (2020)

Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002)

Precision antiplatelet therapy
por: Rocca, Bianca, et al.
Publicado: (2023)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
por: De Luca, Leonardo, et al.
Publicado: (2021)

Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs
por: Patti, Giuseppe, et al.
Publicado: (2018)

COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study
por: Palareti, Gualtiero, et al.
Publicado: (2022)

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
por: Magnani, Giulia, et al.
Publicado: (2023)

Antiplatelet therapy and the vascular tree
por: Blann, A
Publicado: (2006)

Antiplatelets in Secondary Stroke Prevention
por: Shulga, Olga, et al.
Publicado: (2011)

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Antiplatelet Drugs and Endothelial Function
por: Higashi, Yukihito
Publicado: (2016)

Antitcoagulant and antiplatelet activities of scolymoside
por: Yoon, Eun-Kyung, et al.
Publicado: (2015)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review
por: Confalonieri, Filippo, et al.
Publicado: (2023)

Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology
por: Patti, Giuseppe, et al.
Publicado: (2020)

Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies
por: Armstrong, Paul C., et al.
Publicado: (2017)

Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network
por: Gozzo, Lucia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bn42td8h3qbd18l4h92jv79g1f